Join us for this critical discussion about exploding cost in cancer care. Ahead of ASCO, we'll address some of the value frameworks and metrics, and what pharma ought to do to provide better evidence for their prices. You'll get to hear a pretty spirited debate debate between Michael Kolodziej, National Medical Director at Aetna, Steven Paulson, CEO and President at Texas Oncology and our good friend Jack Whelan at Cancer Warrior and Patient Leader.